Google Alert - lose weight

	lose weight As-it-happens update ⋅ February 24, 2026
	NEWS
	Novo Nordisk, United Biotechnology obesity drug trial shows 19.7% weight loss Yahoo Finance COPENHAGEN, Feb 24 () - Novo Nordisk said on Tuesday its ‌triple agonist UBT251 of ‌the receptors for GLP-1, GIP and glucagon, ​jointly developed ... Flag as irrelevant
	New Weight Loss Drugs from Novo Nordisk and Federal Biotechnology Help Patients Lose Weight Bitget Novo Nordisk and United Biotechnology announced that an experimental obesity drug they are co-developing helped patients lose weight in a mi ... Flag as irrelevant
	Novo Nordisk, United Laboratories 'triple G' drug trial shows 19.7% weight loss | Reuters Reuters WEIGHT-LOSS DRUG TARGETS COMBINATION OF HORMONES. UBT251 belongs to a class of drugs that target a combination of gut and pancreatic hormones to ... Flag as irrelevant
	New Kelly Osbourne Photos Spark Vicious Comments About Her Weight Loss - The Looker The Looker - The Daily Beast The TV personality shared several photos on Feb. 23 from the Royal Ascot Millinery Collective SS26 headwear showcase during London Fashion Week on her ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback